Articles by Lisa Drakeman - Pharmaceutical Executive

ADVERTISEMENT

Articles by Lisa Drakeman

Thought Leaders: Playing field in biotech/pharma partnerships levels

May 1, 2005

In the last four or five years—starting in 2000—biotech companies have been able to fund themselves better and are able to do more late-stage development. As biotech companies look toward the future, they do not just want to be research boutiques for the pharmaceutical industry. As a result, pharma companies are accepting the trend towards co-development partnerships for new drugs.

ADVERTISEMENT

Click here